SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as investors discuss the potential impact of its recent acquisition of Ask Sage, a generative AI platform for defense and national security. While some express concerns about revenue declines, others see the acquisition and potential contract announcements as catalysts for significant growth. The community is closely watching for analyst upgrades and anticipates a possible short squeeze.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to a mixed reaction to earnings, with a revenue and EPS beat overshadowed by lowered Q4 guidance attributed to data center delays, sparking volatility. The community is debating whether the dip is a buying opportunity, citing the company's strong AI positioning and massive backlog, while others express concern over profitability and debt. Comparisons to sector peers like NBIS are also circulating.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community speculates on potential catalysts, including a Bitwise ETF filing and the possibility of a broader altcoin season. Talk centers around potential price targets and whether DOGE can rally, while some traders express skepticism about its long-term potential. Discussions also mention Elon Musk's past involvement and the possibility of future support.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending as traders discuss potential catalysts including the end of QT, clarity on regulations, and upcoming upgrades. Community members are weighing in on technical analysis, possible price movements, and the impact of macroeconomic factors like the government shutdown. Some traders are also discussing accumulation by institutions and potential opportunities in related tokens and stocks.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is trending due to positive price action and community excitement around its potential as a key player in the Base ecosystem. Discussions highlight its role as the primary DEX on Coinbase's Base network, with some comparing it to Binance's BNB token and anticipating significant growth. The community is also watching for upcoming events and integrations that could further drive adoption and value.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as community members discuss a potential short squeeze, fueled by recent insider buying from the CEO and institutional investment. Chatter revolves around the impact of upcoming warrants and the possibility of significant price movement, with some speculating on a continued rally. The stock's recent volatility and bullish sentiment are driving increased attention.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap (UNI) is trending as community members highlight its potential for significant gains, with some anticipating a rise to higher price levels. Traders are closely watching UNI, discussing potential breakouts and the possibility of an upcoming alt season. Many believe UNI's underlying fundamentals, like fee generation, support a higher valuation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending amid anticipation for its Phase 3 HOPE-3 trial data release, with the community closely watching for news regarding the timeline and potential FDA submission. Discussions revolve around the flexibility the FDA might show, especially concerning key endpoints like PUL and LVEF, and how these results could impact potential approval. The potential of Deramiocel to address unmet needs in Duchenne Muscular Dystrophy, particularly cardiomyopathy, remains a central talking point.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto (GLTO) is trending due to its acquisition of Damora Therapeutics and a significant funding announcement, leading to high volatility and a surge in trading volume. The community is discussing the potential for a short squeeze, given the stock's low float and high cost to borrow, while also noting the possibility of a pullback or offering. Bullish sentiment is fueled by the company's now secure financial runway through 2029 and pipeline advancements, while some caution against FOMO given the possibility of future share dilution.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark (CLSK) is trending as investors digest the implications of a recent convertible note offering and potential dilution, despite a planned share buyback. The community is debating whether the offering is a strategic move to fund AI expansion or a sign of financial engineering. Discussions also revolve around the company's potential in the AI data center space and comparisons to peers like IREN.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cantor reiterated $CAPR Overweight-$30 and said &quot;Management addressed the recent headlines floating around after recent staffing changes at the FDA.&quot; 
$EWTX $SRPT  
 
Cantor added, &quot;They don&#39;t believe that Dr. Verdun was placed on administrative leave related specifically to $CAPR&#39;s review. 
They suggested that the FDA would be unlikely to take a step this drastic as Dr. Prasad could easily just overrule a decision. 
As of last Friday afternoon, the company was notified that the Agency does not see the need for an advisory committee meeting at this time.&quot;

Green_Dream

ObsOlet

CAPRise

Keith

Oppenheimer reiterated $CAPR at Outperform-$43 and said it has increased confidence heading into deramiocel&#39;s potential approval for DMD cardiomyopathy. 
$EWTX $SRPT 
H.C. Wainwright reiterated $CAPR Buy-$77 and noted $CAPR expressed confidence that its facility is well-positioned to meet FDA requirements - barring future unforeseen issues, HCW believes any current concerns regarding manufacturing are unwarranted. 
 
Oppenheimer said in its note to investors:

StockTwits Web

Edgewise Therapeutics Inc

Sarepta Therapeutics Inc

Quantumup

B.Riley🏁 $CAPR Buy-$21 and said, &quot;We expect post-approval high growth, as Deramiocel expansion could see &gt;$1B in peak revenue.&quot; - &#39;1002 is expected to see favorable comm env w/ 100-200 pt base=$25-$50M in top-line rev w/in 1st Q of launch. 
$PTCT $SRPT $EWTX  
B.Riley said in its initiation report:

Capricor Therapeutics is trending as investors discuss the upcoming data release from its HOPE-3 trial for Duchenne Muscular Dystrophy, with expectations building ahead of the company's conference call. Community sentiment seems cautiously optimistic, with focus on potential FDA approval and the drug's impact on cardiomyopathy, a leading cause of death in DMD patients. Discussions also include potential label expansion and the value of the StealthX exosome platform.

 Overweight-$30 and said "Management addressed the recent headlines floating around after recent staffing changes at the FDA." 


  
 
Cantor added, "They don't believe that Dr. Verdun was placed on administrative leave related specifically to 

's review. 
They suggested that the FDA would be unlikely to take a step this drastic as Dr. Prasad could easily just overrule a decision. 
As of last Friday afternoon, the company was notified that the Agency does not see the need for an advisory committee meeting at this time."